Notice of Intent to Award a Sole Source Commercial Tender - 144620446

Procurement Summary

Country: USA

Summary: Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures Sap Contract for Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potentia...

Deadline: 10 Jul 2026

Posting Date: 06 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 144620446

Document Ref. No.: HFP-2026-134390

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures Sap Contract for Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price contract to Cyprotex US, LLC, 200 Staples Drive, Framingham, MA 01702, USA, incorporated for the purchase of Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental Neurotoxicity, in accordance with the authority under FAR Part 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements.
Cyprotex US, LLC is qualified for DT/OCT/OLOAS/HFP unique requirement because they are the only vendor that offers a neural network formation NAM which utilizes microelectrode array (MEA) technology that can be appropriately adapted for the agency specific needs.
This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.
The North American Industry Classification System (NAICS) code for the proposed acquisition is 541690 - Other Scientific and Technical Consulting Services.
Deliverables
Raw experimental data, noting any deviations from standard procedure - Electronic file (.csv or .RData preferred) - Estimated Delivery Date - 01/31/27
Responses
Responses to this notice should be sent to Haroon Gulzar at [email protected] no later than 5:00 pm (ET) on July 10, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement...
Notice ID: hfp-2026-134390

Department/Ind. Agency: health and human services, department of

Sub-tier: food and drug administration

Office: fda office of acq grant svcs

Product Service Code: b599 - special studies/analysis- other

NAICS Code: 541690 - Other Scientific and Technical Consulting Services

Inactive Dates: jul 25, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice